Organization: Health Canada
Year: 2025
Month: January
Request Number: A-2024-000607
Request Summary: Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_07231496, E2B_07231399, E2B_07234714, 001094399, E2B_07193523, E2B_07229838, E2B_07246719, E2B_07231407, 001092342. ADR for Lansoprazole. Report number: E2B_07246226.
Disposition: Disclosed in part
Number of pages: 472